Related Experiment Video
Updated: May 23, 2026
09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
A network diffusion model of disease progression in dementia
Ashish Raj1, Amy Kuceyeski, Michael Weiner
1Department of Radiology, Weill Medical College of Cornell University, 515 E. 71 Street, Suite S123, New York, NY 10044, USA. ashish@med.cornell.edu
Neuron
|March 27, 2012
Summary
Dementia spreads through brain networks like a prion, not by proximity. Our model predicts dementia patterns and atrophy, aiding diagnosis and prognosis.
Area of Science:
- Neuroscience
- Computational Biology
- Medical Imaging
Background:
- Dementia progression follows distinct brain network patterns, suggesting transsynaptic spread.
- Pathological proteins like tau and beta-amyloid exhibit "prion-like" transmission.
- Understanding dementia spread is crucial for early diagnosis and effective treatment.
Purpose of the Study:
- To develop a quantitative, predictive model of dementia transmission.
- To test the hypothesis of neuronal pathway-mediated disease spread.
- To explore the potential of mathematical modeling for dementia diagnosis and prognosis.
Main Methods:
- Mathematical modeling of diffusive transmission along brain connectivity networks.
- Utilizing tractography data from 14 healthy brain MRIs.
- Graph theoretic analysis to identify "persistent modes" of disease spread.
Main Results:
- The model accurately predicts known dementia patterns and vulnerable brain networks.
- Predicted atrophy patterns align with MRI volumetrics from Alzheimer's and frontotemporal dementia patients.
- Model-derived prevalence rates closely match existing epidemiological data.
Conclusions:
- Neuronal pathway-mediated transmission is a viable model for dementia progression.
- The developed model offers a quantitative tool for differential diagnosis and predicting future atrophy.
- This approach has significant implications for understanding and managing neurodegenerative diseases.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:18Models of Health Promotion and Illness Prevention II
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
The agent-host-environment model states that disease results from...